Effect of resveratrol on NF-kappaB activity in rat peritoneal macrophages

Zhen-Hua Ma1, Qing-Yong Ma, Lian-Cai Wang

  • 1Division of General Surgery of First Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China. mazhenhua2005@163.com

Insights

Resveratrol (RESV) effectively inhibits nuclear factor kappa B (NF-kappaB) activation and pro-inflammatory markers like TNF-alpha and IL-1 in rat macrophages. This suggests RESV

Area of Science:

  • Immunology
  • Pharmacology
  • Cell Biology

Background:

  • Lipopolysaccharide (LPS) is a potent inducer of inflammation in macrophages.
  • Nuclear factor kappa B (NF-kappaB) signaling is a key pathway in inflammatory responses.
  • Resveratrol (RESV) is a natural polyphenol with known anti-inflammatory properties.

Purpose of the Study:

  • To investigate the inhibitory effects of resveratrol (RESV) on LPS-induced NF-kappaB activation.
  • To evaluate the impact of RESV on pro-inflammatory cytokine and nitric oxide production in macrophages.
  • To determine the dose-dependent efficacy of RESV in modulating inflammatory pathways.

Main Methods:

  • Primary rat peritoneal macrophages (PMA) were isolated from Sprague-Dawley rats.
  • Macrophages were stimulated with LPS (10 microg/ml) and treated with varying concentrations of RESV (1.25-10 microg/ml).
  • NF-kappaB activity, TNF-alpha, IL-1, and nitric oxide (NO) levels were measured after 24 hours of incubation.

Main Results:

  • RESV demonstrated a dose-dependent inhibition of NF-kappaB activity in LPS-stimulated PMA.
  • RESV significantly reduced the expression of TNF-alpha, IL-1, and NO in the culture medium.
  • Inhibitory effects were observed at RESV concentrations ranging from 1.25 to 5 microg/ml, with no significant difference between 5 and 10 microg/ml.

Conclusions:

  • Resveratrol effectively suppresses LPS-induced NF-kappaB activation and pro-inflammatory mediator release in rat macrophages.
  • RESV shows potential as a therapeutic agent for preventing inflammatory diseases.
  • These findings highlight the anti-inflammatory capacity of RESV in a cellular model.